These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist, not a GLP-1 RA
The Committees vote is advisory, FDA will make the ultimate determination, and many of the most important questions remain unresolvedincluding how real-world evidence should be weighed, what quality standards should apply, and whether a guarded pathway can move existing use into a more regulated framework
AOD 9604 is not a GH secretagogue
40 Defective IRK activity is also implicated by decreased IRS1 tyrosine phosphorylation which is consistently observed in insulin-resistant skeletal muscles
,
The same research showed an 18% reduction in calorie intake at subsequent meals